- Trials with a EudraCT protocol (94)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
94 result(s) found for: Cell Biology.
Displaying page 1 of 5.
EudraCT Number: 2008-001952-32 | Sponsor Protocol Number: ACA-NETH-07-14 | Start Date*: 2008-11-07 |
Sponsor Name:Radboud University Nijmegen Medical Centre - Department of Dermatology | ||
Full Title: The effect of adalimumab on immune markers in lesional psoriatic skin. | ||
Medical condition: Plaque psoriasis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-000605-72 | Sponsor Protocol Number: CB+MSCforEB | Start Date*: 2014-02-06 |
Sponsor Name:Universitair Medisch Centrum Utrecht | ||
Full Title: Unrelated cord blood transplantation after reduced toxicity conditioning with mesenchymal stromal cell co-infusion in patients with severe epidermolysis bullosa | ||
Medical condition: The source population consists of patients referred to or within the UMC Groningen because they have diagnosed clinically and genetically severe generalized RDEB. | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000900-41 | Sponsor Protocol Number: WB28850 | Start Date*: 2013-05-10 |
Sponsor Name:F. Hoffmann-La Roche, Ltd. | ||
Full Title: A STUDY TO MEASURE SERUM PERIOSTIN, ASTHMA-RELATED BIOMARKERS AND RESPONSE TO PREDNISOLONE IN ADULT AND ADOLESCENT PATIENTS WITH SEVERE ORAL CORTICOSTEROID-DEPENDENT ASTHMA | ||
Medical condition: Severe corticosteroid-dependent asthma | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-001557-85 | Sponsor Protocol Number: 5.0 | Start Date*: 2011-08-22 | |||||||||||
Sponsor Name:Nordic Lymphoma Group | |||||||||||||
Full Title: NLG-MCL5 (MARiT) Rituximab, High Dose Ara-C and Dexamethasone Followed by BEAM in Mantle Cell Lymphoma Patients <66 years A Nordic Lymphoma Group and British Lymphoma Group Phase-II Trial | |||||||||||||
Medical condition: Mantle cell lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) DK (Prematurely Ended) FI (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004039-30 | Sponsor Protocol Number: MCL5(MARiT) | Start Date*: 2012-04-03 | |||||||||||
Sponsor Name:PLymouth Hospitals NHS Trust | |||||||||||||
Full Title: Rituximab, High Dose Ara-C and Dexamethasone Followed by BEAM in Mantle Cell Lymphoma Patients <66 Years | |||||||||||||
Medical condition: Mantle Cell Lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-006372-17 | Sponsor Protocol Number: Field-Cancerization | Start Date*: 2022-02-15 | |||||||||||
Sponsor Name:Muehlenkreiskliniken AoeR | |||||||||||||
Full Title: Evaluation of clinical and immunological effects of PD-1 inhibition on actinic keratoses in patients with advanced or metastatic cutaneous squamous cell carcinoma in combination with a pronounced f... | |||||||||||||
Medical condition: advanced or metastatic cutaneous squamous cell carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002234-14 | Sponsor Protocol Number: OR2805-101 | Start Date*: 2023-06-07 |
Sponsor Name:OncoResponse, Inc. | ||
Full Title: A Phase 1-2 Study of OR2805 Alone and in Combination with other Anti-cancer Agents in Subjects with Advanced Malignancies | ||
Medical condition: Solid tumor cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001447-31 | Sponsor Protocol Number: 2018/2706 | Start Date*: 2018-08-02 |
Sponsor Name:Gustave Roussy | ||
Full Title: Phase II trial of nivolumab for pediatric and adult relapsing/refractory ALK+ anaplastic large cell lymphoma, for evaluation of response in patients with progressive disease (Cohort 1) or as consol... | ||
Medical condition: Relapsing/Refractory ALK+ Anaplastic Large cell Lymphoma | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: FR (Ongoing) DK (Ongoing) NL (Ongoing) DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-003041-35 | Sponsor Protocol Number: TJB2224 | Start Date*: 2022-10-20 |
Sponsor Name:CHU de Liège | ||
Full Title: Impact of the immune system on response to inactivated influenza vaccine (IIV) in allogeneic stem cell recipients | ||
Medical condition: Allogeneic hematopoietic stem cell recipients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000903-14 | Sponsor Protocol Number: CRO685 | Start Date*: 2007-07-17 | ||||||||||||||||||||||||||
Sponsor Name:Imperial College, London | ||||||||||||||||||||||||||||
Full Title: Randomized Phase III Trial to evaluate the effect of statins on tumour biology in non-small cell lung cancer. | ||||||||||||||||||||||||||||
Medical condition: Non-small cell lung cancer | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-001628-45 | Sponsor Protocol Number: 2.0 | Start Date*: 2015-09-09 |
Sponsor Name:Dep. of Medical Cell Biology Uppsala University | ||
Full Title: A parallel, double-blinded, randomized, 6 months, two arms study with lifestyle intervention and exenatide 2 mg once weekly or lifestyle intervention and placebo in adolescents with obesity to expl... | ||
Medical condition: Obesity in adolescents | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004876-31 | Sponsor Protocol Number: 204745 | Start Date*: 2016-03-28 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: An open-label, single arm study to investigate the safety, pharmacokinetics and pharmacodynamics of repeat doses of inhaled nemiralisib in patients with APDS/PASLI | |||||||||||||
Medical condition: patients with APDS/PASLI | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003760-47 | Sponsor Protocol Number: 2018-14 | Start Date*: 2020-04-06 |
Sponsor Name:Assistance Publique Hôpitaux de Marseille | ||
Full Title: Evaluation of 68Ga-PSMA PET-CT in the initial extension assessment of advanced renal cell carcinoma a prospective, multicenter, open study | ||
Medical condition: renal cell cancer (RCC) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006384-37 | Sponsor Protocol Number: NP22383 | Start Date*: 2009-10-06 | |||||||||||||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||||||||||||
Full Title: A phase II study of orally administered RO4929097, a gamma-secretase inhibitor, as a single agent in patients with recurrent or refractory Non-Small Cell Lung Cancer (NSCLC). | |||||||||||||||||||||||
Medical condition: Patients with recurrent or refractory stage IIIB/IV NSCLC. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-004153-93 | Sponsor Protocol Number: iEuroEwing | Start Date*: 2022-06-17 |
Sponsor Name:German Paediatric Oncology Group | ||
Full Title: INTERNATIONAL EURO EWING TRIAL FOR TREATMENT OPTIMISATION IN PATIENTS WITH EWING SARCOMA | ||
Medical condition: Ewing Sarcoma | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-002697-80 | Sponsor Protocol Number: MADI-02 | Start Date*: Information not available in EudraCT |
Sponsor Name:Université Libre de Bruxelles | ||
Full Title: Maternal determinants of infant immunity to pertussis | ||
Medical condition: Vaccination against whooping cough in non-pregnant women and in pregnant women. Vaccination against whooping cough in the Belgian vaccination program in children from 2 months of age | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18, Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000572-15 | Sponsor Protocol Number: EGF117268 | Start Date*: 2013-07-01 |
Sponsor Name:GlaxoSmithKline Research & Development Ltd | ||
Full Title: Investigation of immune mechanisms relating to lapatinib associated hepatotoxicity: ex vivo T cell biology investigation relating to lapatinib induced liver adverse events using PBMCs from patie... | ||
Medical condition: The subjects participated in the EGF105485 study, a randomized, placebo-controlled study of lapatinib in HER2-positive early-stage breast cancer. During participation in this study, subjects had b... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DK (Completed) ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001201-93 | Sponsor Protocol Number: CABOPRE | Start Date*: 2018-09-19 | |||||||||||
Sponsor Name:Fundación ONCOSUR | |||||||||||||
Full Title: Phase II study for the evaluation of neoadjuvant treatment with cabozantinib prior to cytoreductive nephrectomy in patients with locally advanced or metastatic renal cell carcinoma | |||||||||||||
Medical condition: Locally Advanced or Metastatic Renal Cell Carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002196-34 | Sponsor Protocol Number: Neo.Lu.Pa.NET | Start Date*: 2019-11-07 | |||||||||||
Sponsor Name:OSPEDALE SAN RAFFAELE | |||||||||||||
Full Title: A Prospective Phase II Single-Arm Trial on Neoadjuvant Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE Followed by Surgery for resectable Pancreatic Neuroendocrine Tumors (Neo.Lu.Pa.NET) | |||||||||||||
Medical condition: Resectable pancreatic neuroendocrine tumors | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-007076-15 | Sponsor Protocol Number: 04-006 | Start Date*: 2008-02-01 | |||||||||||
Sponsor Name:Dana Farber Cancer Institute | |||||||||||||
Full Title: A Randomized Phase III Trial Comparing Sequential Therapy With TPF/Chemoradiation (ST) To Cisplatin-Based Chemoradiotherapy with Accelerated Concomitant Boost Radiotherapy (CRT) For Locally Advance... | |||||||||||||
Medical condition: Squamous cell carcinoma of the head and neck [SCCHN]. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.